BofA Merrill Lynch,
The public offering will be made pursuant to a shelf registration statement (File No. 333-224020) on Form S-3 that was filed by Audentes with the
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
This press release contains forward-looking statements within the meaning of the
View original content to download multimedia:http://www.prnewswire.com/news-releases/audentes-therapeutics-announces-proposed-public-offering-of-common-stock-300728090.html